IHI vs MDEV: Holdings Overlap & Returns
Over the year to Nov 13, 2026, IHI returned −7.4% to MDEV's +8.8%; 33% of their weight is in the same names.
- Return gap
- +16.2 pts1 year to Nov 13, 2026: MDEV ahead, total return
- Fee gap
- 0.33 ptsA year: IHI 0.37%, MDEV 0.70%, per filings dated Jul 27, 2026 and Jul 29, 2026
- Overlap
- 33%Share of the two books held in common, holdings dated Nov 12, 2026
- Net flow
- +$76m / $0kIHI / MDEV, Oct 13, 2026 to Nov 12, 2026, daily basis
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
IHI −7.4%, MDEV +8.8%: MDEV +16.2 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Cost to trade
Hypothetical. A $10,000 order in IHI costs about $1.00 one way and $2.00 in and out, at a median spread of 0.02%. The 0.02% spread is IHI’s 30-day median, from iShares (fund page).
Fees over time
Hypothetical. $10,000 in MDEV for 10 years at 0.70% a year costs about $1,148 in fees and lost growth; IHI at 0.37% would cost $615. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
89% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.
48% of MDEV's weight is in S&P 500 companies and 52% is outside the index. Holdings as of Nov 12, 2026.
Key numbers
IHI costs 0.33 points a year less; their one-year returns differ by 16.2 points; IHI is far larger, $4.0bn against $3.4m.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | −7.4% | +8.8% |
|---|---|---|
| Below its all-time high | 11.5%, high on Sep 8, 2021 | 19.1%, high on Sep 7, 2021 |
| What it tracks | Therapeutics and medical devices | Therapeutics and medical devices |
| Expense ratio | 0.37% | 0.70% |
| Net assets, as of Nov 12, 2026 | $4.0bn | $3.4m |
| Holdings in common | 33% |
The numbers behind it
Net assets: $4.1bn on Nov 13, 2026 for iShares U.S. Medical Devices ETF, and $3.4m on Nov 12, 2026 for First Trust Indxx Medical Devices ETF.
Holdings in common uses holdings dated Nov 12, 2026.
What they share
By the books each fund has filed, IHI and MDEV hold 33% of their money in the same securities at the same weight. Holdings dated Nov 12, 2026.
half
33% in common
Held in common
Show all 12 holdings
| GE HEALTHCARE TECHNOLOGIES | 4.63% | 2.35% |
| EDWARDS LIFESCIENCES | 4.96% | 2.34% |
| STERIS | 3.10% | 2.23% |
| BECTON DICKINSON AND CO | 4.85% | 2.21% |
| ZIMMER BIOMET HOLDINGS | 2.50% | 2.21% |
| MEDTRONIC PLC | 11.51% | 2.15% |
| STRYKER | 4.59% | 2.13% |
| ABBOTT LABORATORIES | 17.27% | 2.03% |
| INTUITIVE SURGICAL | 14.46% | 1.96% |
| RESMED | 4.32% | 1.96% |
| BOSTON SCIENTIFIC | 3.98% | 1.95% |
| DEXCOM INC | 3.85% | 1.82% |
Only in IHI
Show all 8 holdings
| IDEXX LABORATORIES | 5.48% |
| GLAUKOS | 1.82% |
| INTEGER HOLDINGS CORP | 0.54% |
| ENVISTA HOLDINGS | 0.50% |
| AXOGEN | 0.41% |
| TRANSMEDICS GROUP | 0.40% |
| IRHYTHM HOLDINGS INC | 0.39% |
| ATRICURE | 0.36% |
Only in MDEV
Show all 8 holdings
| Koninklijke Philips N.V. | 2.33% |
| Straumann Holding AG (Registered) | 2.24% |
| Align Technology, Inc. | 2.20% |
| Cochlear Limited | 2.19% |
| Smith & Nephew Plc | 2.16% |
| The Cooper Companies, Inc. | 2.15% |
| Alcon Inc. | 2.13% |
| West Pharmaceutical Services, Inc. | 2.12% |
Side by side
Open the table
| Fund | iShares U.S. Medical Devices ETF · Holds 51 stocks in therapeutics and medical devices, 88% of its weight in S&P 500 companies | First Trust Indxx Medical Devices ETF · Holds 50 stocks in therapeutics and medical devices, 48% of its weight in S&P 500 companies |
| Issuer | iShares | First Trust |
| Theme | Therapeutics and medical devices | Therapeutics and medical devices |
| In the S&P 500 | 88.5% | 47.8% |
| Active share vs the S&P 500 | 98.7% | 98.0% |
| In the Nasdaq-100 | 28.4% | 6.1% |
| Holdings | 51 | 50 |
| Top ten, share of the fund | 76.0% | 22.6% |
| Expense ratio | 0.37% | 0.70% |
| Fee for the differing part | 0.37% | 0.71% |
| Total return, 1 year | −7.4% | +8.8% |
| vs its benchmark | not measured | not measured |
| Below its high | −11.5% | −19.1% |
| Net assets, IHI as of Nov 13, 2026 and MDEV as of Nov 12, 2026 | $4.1bn | $3.4m |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +4.2% | +5.5% |
|---|---|---|
| 6 months | +20.1% | +26.9% |
| 1 year | −7.4% | +8.8% |
| 3 years | +23.4% | +27.4% |
| Since launch (Not the same days: IHI May 2006 · MDEV Jun 2021) | +658.0% | −10.2% |
About IHI
By weight, 88% of IHI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 76% of the fund across 51 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned −7.4% with distributions reinvested. It sits 11.5% below its all-time high of Sep 8, 2021.
About MDEV
By weight, 48% of MDEV's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 23% of the fund across 50 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned +8.8% with distributions reinvested. It sits 19.1% below its all-time high of Sep 7, 2021.
33% of the two portfolios are the same securities at the same weight.
Questions people ask
Do IHI and MDEV hold the same stocks?
By their latest filings, 33% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, IHI against MDEV, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ihi-vs-mdev
ETFIQ. (Nov 13, 2026). IHI against MDEV. Retrieved from https://etfiq.com/compare/themes/ihi-vs-mdev
[IHI against MDEV (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/ihi-vs-mdev)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.